Back
VolitionRX Vs. Perspective Therapeutics Industry Stock Comparison
Sell
36
VNRX
VolitionRX
Last Price:
0.88
Seasonality Move:
-8.55%
Buy
75
CATX
Perspective Therapeutics
Last Price:
1.72
Seasonality Move:
2.36%
Sell
36
VolitionRX (VNRX)
is a Sell
Is VolitionRX a Buy, Sell or Hold?
- The current VolitionRX [VNRX] share price is $0.88. The Score for VNRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- VNRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.74. The Score for CATX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VNRX Stock Price Chart
What is VolitionRX's stock price today?
-
The VolitionRX share price today is $0.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNRX is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.74
The current trend is moderately bullish and CATX is experiencing slight buying pressure.
VNRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 56.66 | Buy |
| Chaikin Money Flow: | 145768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.87) | Buy |
| Bollinger Bands (100): | (0.73 - 1.05) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.65 | Buy |
| Chaikin Money Flow: | 2180568 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.5 - 1.76) | Buy |
| Bollinger Bands (100): | (0.6 - 1.48) | Buy |
VNRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Buy |
| 20-day SMA: | 0.78 | Buy |
| 50-day SMA: | 0.81 | Buy |
| 200-day SMA: | 0.91 | Sell |
| 8-day EMA: | 0.82 | Buy |
| 20-day EMA: | 0.8 | Buy |
| 50-day EMA: | 0.82 | Buy |
| 200-day EMA: | 1 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Sell |
| 20-day SMA: | 1.66 | Buy |
| 50-day SMA: | 1.42 | Buy |
| 200-day SMA: | 0.69 | Buy |
| 8-day EMA: | 1.75 | Sell |
| 20-day EMA: | 1.67 | Buy |
| 50-day EMA: | 1.44 | Buy |
| 200-day EMA: | 0.88 | Buy |
VolitionRX Earnings Growth & VNRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.10 per share, and an increase next year of $0.09 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VolitionRX Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||